skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 179  for All Library Resources

Results 1 2 3 4 5 next page
Refined by: creation date: After 2012 remove resource type: Standards remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Atogepant for preventing migraine
Material Type:
Standards
Add to My Research

Atogepant for preventing migraine

NICE Guidance, 2024

Copyrights: © NICE 2024 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

2
Selinexor with bortezomib and dexamethasone for previously treated multiple myeloma
Material Type:
Standards
Add to My Research

Selinexor with bortezomib and dexamethasone for previously treated multiple myeloma

NICE Guidance, 2024

Copyrights: © NICE 2024 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

3
Selinexor with dexamethasone for treating relapsed or refractory multiple myeloma after 4 or more treatments
Material Type:
Standards
Add to My Research

Selinexor with dexamethasone for treating relapsed or refractory multiple myeloma after 4 or more treatments

NICE Guidance, 2024

Copyrights: © NICE 2024 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

4
Digital technologies to deliver pulmonary rehabilitation programmes for adults with COPD: early value assessment
Material Type:
Standards
Add to My Research

Digital technologies to deliver pulmonary rehabilitation programmes for adults with COPD: early value assessment

NICE Guidance, 2024

Copyrights: © NICE 2024 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

5
Ritlecitinib for treating severe alopecia areata in people 12 years and over
Material Type:
Standards
Add to My Research

Ritlecitinib for treating severe alopecia areata in people 12 years and over

NICE Guidance, 2024

Copyrights: © NICE 2024 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

6
Dupilumab for treating moderate to severe prurigo nodularis
Material Type:
Standards
Add to My Research

Dupilumab for treating moderate to severe prurigo nodularis

NICE Guidance, 2024

Copyrights: © NICE 2024 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

7
Talazoparib for treating HER2-negative advanced breast cancer with germline BRCA mutations
Material Type:
Standards
Add to My Research

Talazoparib for treating HER2-negative advanced breast cancer with germline BRCA mutations

NICE Guidance, 2024

Copyrights: © NICE 2024 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

8
Olaparib with abiraterone for untreated hormone-relapsed metastatic prostate cancer
Material Type:
Standards
Add to My Research

Olaparib with abiraterone for untreated hormone-relapsed metastatic prostate cancer

NICE Guidance, 2024

Copyrights: © NICE 2024 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

9
Epilepsies in children, young people and adults
Material Type:
Standards
Add to My Research

Epilepsies in children, young people and adults

NICE Guidance, 2023

Copyrights: © NICE 2023 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

10
Cardiovascular disease: risk assessment and reduction, including lipid modification
Material Type:
Standards
Add to My Research

Cardiovascular disease: risk assessment and reduction, including lipid modification

NICE Guidance, 2023

Copyrights: © NICE 2023 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

11
Velmanase alfa for treating alpha-mannosidosis
Material Type:
Standards
Add to My Research

Velmanase alfa for treating alpha-mannosidosis

NICE Guidance, 2023

Copyrights: © NICE 2023 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

12
Secukinumab for treating moderate to severe hidradenitis suppurativa
Material Type:
Standards
Add to My Research

Secukinumab for treating moderate to severe hidradenitis suppurativa

NICE Guidance, 2023

Copyrights: © NICE 2023 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

13
Zanubrutinib for treating chronic lymphocytic leukaemia
Material Type:
Standards
Add to My Research

Zanubrutinib for treating chronic lymphocytic leukaemia

NICE Guidance, 2023

Copyrights: © NICE 2023 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

14
Suspected acute respiratory infection in over 16s: assessment at first presentation and initial management
Material Type:
Standards
Add to My Research

Suspected acute respiratory infection in over 16s: assessment at first presentation and initial management

NICE Guidance, 2023

Copyrights: © NICE 2023 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

15
Tirzepatide for treating type 2 diabetes
Material Type:
Standards
Add to My Research

Tirzepatide for treating type 2 diabetes

NICE Guidance, 2023

Copyrights: © NICE 2023 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

16
Stroke rehabilitation in adults
Material Type:
Standards
Add to My Research

Stroke rehabilitation in adults

NICE Guidance, 2023

Copyrights: © NICE 2023 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

17
Rimegepant for treating migraine
Material Type:
Standards
Add to My Research

Rimegepant for treating migraine

NICE Guidance, 2023

Copyrights: © NICE 2023 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

18
Artificial intelligence-derived software to analyse chest X-rays for suspected lung cancer in primary care referrals: early value assessment
Material Type:
Standards
Add to My Research

Artificial intelligence-derived software to analyse chest X-rays for suspected lung cancer in primary care referrals: early value assessment

NICE Guidance, 2023

Copyrights: © NICE 2023 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

19
KardiaMobile 6L for measuring cardiac QT interval in adults having antipsychotic medication
Material Type:
Standards
Add to My Research

KardiaMobile 6L for measuring cardiac QT interval in adults having antipsychotic medication

NICE Guidance, 2023

Copyrights: © NICE 2023 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

20
Pembrolizumab for previously treated endometrial, biliary, colorectal, gastric or small intestine cancer with high microsatellite instability or mismatch repair deficiency
Material Type:
Standards
Add to My Research

Pembrolizumab for previously treated endometrial, biliary, colorectal, gastric or small intestine cancer with high microsatellite instability or mismatch repair deficiency

NICE Guidance, 2023

Copyrights: © NICE 2023 All rights reserved. Subject to Notice of rights

Digital Resources/Online E-Resources

Results 1 - 20 of 179  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 2017  (9)
  2. 2017 To 2018  (35)
  3. 2019 To 2020  (37)
  4. 2021 To 2023  (91)
  5. After 2023  (8)
  6. More options open sub menu

Searching Remote Databases, Please Wait